Clinical Trial: A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects

U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07267130) titled 'A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects' on Nov. 25.

Brief Summary: Healthy adult subjects were selected to use TQC3302 inhalation spray to evaluate the safety, tolerability, and pharmacokinetic characteristics of single and multiple inhalations of TQC3302 inhalation spray in healthy participants.

Study Start Date: Nov. 25

Study Type: INTERVENTIONAL

Condition: Chronic Obstructive Pulmonary Disease

Intervention: DRUG: TQC3302 inhalation spray

TQC3302 inhalation spray is a targeted inhibitor

DRUG: TQC3302 inhalation spray+ TQC3302 in...